Endothelial injury in childhood stroke with cerebral arteriopathy
A cross-sectional study
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 18, 2012
- Accepted June 21, 2012
- First Published October 17, 2012.
Article Versions
- Previous version (October 17, 2012 - 13:02).
- You are viewing the most recent version of this article.
Author Disclosures
- Despina Eleftheriou, MBBS,
- Vijeya Ganesan, MD,
- Ying Hong, PhD,
- Nigel J. Klein, PhD and
- Paul A. Brogan, PhD
- Despina Eleftheriou, MBBS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Action medical research fellowship grant RTF 1355
NONE
NONE
NONE
NONE
NONE
NONE
- Vijeya Ganesan, MD,
NONE
NONE
NONE
Developmental Medicine Child Neurology, Editorial Board, 2011-current
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ying Hong, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Arthritis research UK and a National Institute for Health Research/Biomedical Research Centre project grant.
NONE
NONE
NONE
NONE
NONE
NONE
- Nigel J. Klein, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Paul A. Brogan, PhD
1. Scientific advisor to Roche in relation to design of our clinical trial of rituximab in children with ANCA vasculitis 2011- 2012
NONE
1. Payment/stipend and travel expenses from the American society of nephrology 2011 to give a talk at the annual ASN meeting, Philadelphia 2011
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1. Aspreva. A randomised clinical trial of mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis in children 1/6/2008-30/9/2011 2. Wellcome Trust. The UK National Juvenile Dermatomyositis Cohort. 1/1/2009-31/12/2011 3. HEFCE. Clinical Senior Lecturer Fellowship. 1/3/2009-28/2/2014 4. Action Medical Research.Inflammation and endothelial injury in childhood central nervous system vasculitis: identifying biomarkers predictive of disease progression. PhD Fellowship for Dr D Eleftheriou. 1/8/09-31/7/2012 5. Arthritis Research UK. The vasculopathy of Juvenile dermatomyositis. 1/9/09-1/3/10 6. Nuffield Foundation Oliver Bird Rheumatism Programme. Homozygosity mapping for the discovery of novel autoinflammatory disease.1/09/2009-31/08/2012 7. Great Ormond St Hospital Children's Charity. Endothelial injury and repair in vasculitis of the young.1/10/2010-28/2/2011 8. Novartis: One year open-label multicentre trial to assess efficacy, safety and tolerability of canakinumab in patients aged four years or younger with cryopyrin associated periodic syndromes (CAPS). 1/4/2011-31/3/2012 9. Biomedical Research Centre NIHR grant. Neutrophil microparticles in the pathogenesis of ANCA associated vasculitis. 1/3/2011-1/8/2012 10. British Heart Foundation. Subclinical vasculitis, late vasculopathy and myocardial performance years after Kawasaki disease in the UK. 1/5/11-30/4/2013
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1. Expert legal witness in UK in the last two years.
- From the Paediatric Rheumatology Department (D.E., Y.H., P.A.B.), Neurosciences Unit (V.G.), and Infectious Diseases and Microbiology Unit (N.J.K.), Institute of Child Health and Great Ormond St Hospital for Children, London, UK.
- Correspondence & reprint requests to Dr. Eleftheriou: d.eleftheriou{at}ich.ucl.ac.uk
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.